KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.
about
Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection.New generation humanized mice for virus research: comparative aspects and future prospectsUpregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressIntracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components.Progressive accumulation of activated ERK2 within highly stable ORF45-containing nuclear complexes promotes lytic gammaherpesvirus infectionKSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.Non-human primate model of Kaposi's sarcoma-associated herpesvirus infectionPivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.Increased tumorigenicity of cells carrying recombinant human herpesvirus 8.Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaHumanized mouse models of epstein-barr virus infection and associated diseases.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Immune evasion by Kaposi's sarcoma-associated herpesvirus.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisPrevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells.Sphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells.The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodesKaposi's sarcoma and its associated herpesvirus.Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesvirusesHuman herpesvirus 6A infection and immunopathogenesis in humanized Rag2⁻/⁻ γc⁻/⁻ mice.Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication.Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.Human immune responses and potential for vaccine assessment in humanized mice.Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?KSHV targeted therapy: an update on inhibitors of viral lytic replication.Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus.Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA.Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients.Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus.In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
P2860
Q24670607-0322434D-E4AE-4EBB-B1CD-F3C5A43F6753Q27014786-303FD913-6E5D-4629-BF66-C5748C1CB53CQ28472699-4357923D-DF5C-490D-8B9E-737AC771AF91Q28757509-0ED84E7E-364B-431D-90EC-92C797B9064CQ30413848-66AEFF6E-3D66-4A1A-97A1-4F2EDED5511CQ30433391-95A25D9E-E8D8-4143-AAEB-37058642E464Q33507742-4FE96636-EA86-4544-8DA1-F043467FCF71Q33508240-D05613E5-1863-49AE-B088-19C5EE02A007Q33571183-62AD1588-FBB0-4006-B275-7D304EB0CE57Q33585787-048832A0-87C2-4043-9070-FF28613F6C47Q34130226-DD4E5514-CA45-45A5-8EE9-D904308B4FACQ34533579-FB2C8622-B2C7-4B13-BCCB-D875FE0E178BQ34615002-40AACE78-C1A6-4B64-A06D-3E80BB76F255Q34795543-D2EB78CA-1C05-41CE-900B-E4737153E0DAQ35124404-5BEA3554-1959-4154-A46C-F343FAD5F19FQ35143080-05B0E3ED-2132-48F9-A639-23849155AAC6Q35204641-209CA4A3-0142-4B77-94E3-B98F7468D76BQ35206268-63ED1DF3-A2A7-44BB-BDE1-7A9E445045BFQ35453657-AA9AE9D6-5996-4F98-9F48-292AE37B9B89Q35453802-FD73E6B9-2091-475F-ABB6-3EFBA04EED71Q35785343-8FB356A1-1DEA-45ED-913B-59C80D6F8388Q36487309-8B41B2B4-6F19-45DD-A18F-58435D8580A7Q36759709-A02B0EA6-B566-4DFE-A01E-8B1BECBA283BQ37254302-879259F8-572C-42DA-BADD-187FD0971526Q37525707-3B2E9024-0612-4872-8141-0B875E3814AFQ37612729-2066CEE5-748A-49BB-9307-150BB7D83645Q38102807-3EA235D4-AEC7-46BE-B79A-084430A53A73Q38186778-1B5FE4D9-00E6-4393-BC0D-DD6DDB58A860Q38271135-212A78A2-A15C-478B-AEB8-25DE29AF92BFQ38787325-0F0F7FDD-1856-40B0-B134-38729486DE22Q38943741-F4E8DBA4-5F1A-4F2F-A0BE-1C40F51C59FAQ39323923-E10F6D37-20F5-40F8-8DAF-C2DB60AF886CQ39602242-2EDC6FD1-B8CF-4055-83F8-70E7618A0D3DQ39744147-39005F1A-8251-407C-BDAE-A4EE7BF17714Q40041231-16627CDB-B547-443B-85F6-33A4FA1F2C87Q40417350-47889962-C01D-4B28-A352-7BAF7A7DB844Q41365661-A14030C7-7F89-4D51-8390-715196F8C581Q41839438-7D0ABE00-2684-4B44-AFA9-FE2DEC1BA09CQ47551073-E10DD864-8503-41CF-B756-449CE0B7900EQ57462211-4FECB6E1-08D4-4EAE-884F-4D8C27404755
P2860
KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@ast
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@en
type
label
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@ast
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@en
prefLabel
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@ast
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@en
P2093
P2860
P356
P1476
KSHV targets multiple leukocyt ...... ve infection in NOD/SCID mice.
@en
P2093
Christine M O'Connor
Christopher H Parsons
David Camerini
Dean H Kedes
J Robert Taylor
Jon Overdevest
Laura A Adang
P2860
P304
P356
10.1172/JCI27249
P407
P577
2006-06-22T00:00:00Z